Merger Results in Leading Company for Oncolytic Adenoviruses for Cancer HOUSTON, TX– October 23, 2012 – DNAtrix, Inc., the Houston-based biotechnology company developing targeted adenovirus-based oncolytic virus products, announced today.. read more